Quantitative comparison between the transplantability of human and murine tumors into the brain of NCr/Sed-nu/nu nude and severe combined immunodeficient mice
- PMID: 8402693
Quantitative comparison between the transplantability of human and murine tumors into the brain of NCr/Sed-nu/nu nude and severe combined immunodeficient mice
Abstract
We have demonstrated (A. Taghian et al., Cancer Res., 53: 5012-5017, 1993) that the take rate of human xenografts in the s.c. tissue of severe combined immunodeficient (SCID) mice is significantly higher than that of nude mice. Earlier, this laboratory reported that the transplantability of tumor xenografts was significantly higher for intracranial (i.c.) injection than for s.c. injection in nude mice. The purpose of this study is to assess: (a) the relative i.c. transplantability of human and murine tumors in comparison with s.c. tissue in SCID mice; (b) the relative i.c. transplantability in SCID mice in comparison to nude mice; and (c) the influence of whole-body irradiation on i.c. transplantability of SCID and nude mice. The assay based on the number of cells required to transplant tumors into 50% of recipients (TD50) was used to describe the transplantability assays. Five human and four murine tumor cell lines were used. Concurrent TD50 assays were performed i.c. in whole-body irradiated and nonirradiated SCID and nude mice. Serial 2-10-fold dilutions of cells were injected in a 10-microliters volume into the right parietal lobe 3 mm below the skin. The results showed that in all tumors studied the i.c. TD50S were significantly lower than the s.c. TD50S by a factor of 1.7-1580. The average enhancement ratio (s.c. TD50/i.c. TD50) in nude mice was twice that in SCID mice. No significant difference was found between the i.c. TD50S in SCID and in nude mice, contrary to the significant difference in s.c. TD50S between both strains of mice (A. Taghian et al., Cancer Res., 53: 5012-5017, 1993). Whole-body irradiation did not significantly affect the i.c. TD50 in nude mice; however, it did affect two of three xenografts in SCID mice. In conclusion, despite the significantly lower s.c. TD50S of human xenografts in SCID mice, i.c. TD50S were almost similar to those of NCr/Sed-nu/nu nude mice. This suggests the presence of different immunoreactivities between nude and SCID mice in s.c. transplantability; however, for i.c. transplantability, nude mice behaved equally as well as SCID mice. The significant enhancement ratio in SCID mice is further evidence that this strain of mice displays a residual systemic immunoreactivity, although the immunoreactivity is significantly lower than that of nude mice.
Similar articles
-
Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice.Cancer Res. 1993 Oct 15;53(20):5012-7. Cancer Res. 1993. PMID: 8402692
-
Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice.Cancer Res. 1988 Nov 15;48(22):6510-6. Cancer Res. 1988. PMID: 3052803
-
The effect of whole-body irradiation of nude mice on the tumor transplantability and control probability of a human soft tissue sarcoma xenograft.Radiat Res. 1996 Mar;145(3):337-42. Radiat Res. 1996. PMID: 8927702
-
The study of human neoplastic disease in severe combined immunodeficient mice.Lab Anim Sci. 1993 Apr;43(2):139-46. Lab Anim Sci. 1993. PMID: 8320961 Review.
-
Tissue culture and transplantation of breast cancer.Prog Clin Biol Res. 1977;12:55-70. Prog Clin Biol Res. 1977. PMID: 335406 Review. No abstract available.
Cited by
-
The combination of adenoviral HSV TK gene therapy and radiation is effective in athymic mouse glioblastoma xenografts without increasing toxic side effects.J Neurooncol. 2004 Mar-Apr;67(1-2):177-88. doi: 10.1023/b:neon.0000021897.53969.ca. J Neurooncol. 2004. PMID: 15072465
-
Comparison of Genetically Engineered Immunodeficient Animal Models for Nonclinical Testing of Stem Cell Therapies.Pharmaceutics. 2021 Jan 20;13(2):130. doi: 10.3390/pharmaceutics13020130. Pharmaceutics. 2021. PMID: 33498509 Free PMC article. Review.
-
Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors.Cancers (Basel). 2022 Oct 18;14(20):5108. doi: 10.3390/cancers14205108. Cancers (Basel). 2022. PMID: 36291891 Free PMC article. Review.
-
Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.Mol Pathol. 2001 Aug;54(4):230-9. doi: 10.1136/mp.54.4.230. Mol Pathol. 2001. PMID: 11477137 Free PMC article.
-
Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7263-8. doi: 10.1073/pnas.93.14.7263. Proc Natl Acad Sci U S A. 1996. PMID: 8692980 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Molecular Biology Databases
Research Materials